Biology Reference
In-Depth Information
Dietschy, J.M., and Turley, S.D. (2001). Cholesterol metabolism in the brain.
Current
Opinion in Lipidology, 12,
105-112.
Dodart, J.C., Bales, K.R., Gannon, K.S., Greene, S.J., DeMattos, R.B., Mathis, C., DeLong,
C.A., Wu, S., Wu, X., Holtzman, D.M., and Paul, S.M. (2002). Immunization reverses
memory deficits without reducing brain Aβ burden in Alzheimer's disease model.
Nature
Neuroscience, 5,
452-457.
Dodson, S.E., Gearing, M., Lippa, C.F., Montine, T.J., Levey, A.I., and Lah, J.J. (2006).
LR11/SorLA expression is reduced in sporadic Alzheimer disease but not in familial
Alzheimer disease.
Journal of Neuropathology and Experimental Neurology, 65,
866-
872.
Dhavan, R., and Tsai, L.H. (2001). A decade of CDK5.
Nature Reviews Molecular Cell
Biology, 2,
749-759.
Ehlers, M.D. (2000). Reinsertion or degradation of AMPA receptors determined by activity-
dependent endocytic sorting.
Neuron, 28,
511-525.
Einstein, G., Buranosky, R., and Crain, B.J. (1994). Dendritic pathology of granule cells in
Alzheimer's disease is unrelated to neuritic plaques.
Journal of Neuroscience, 14,
5077-
5088.
Engel, T., Hernández, F., Avila, J., and Lucas, J.J. (2006). Full reversal of Alzheimer's
disease-like phenotype in a mouse model with conditional overexpression of glycogen
synthase kinase-3.
Journal of Neuroscience, 26,
5083-5090.
English, J.D., and Sweatt, J.D. (1996). Activation p42 mitogen-activated protein kinase in
hippocampal long term potentiation.
Journal of Biological Chemistry, 271,
24329-24332.
Esposito, D., Patel, P., Stephens, R.M., Perez, P., Chao, M.V., Kaplan, D.R., and Hempstead,
B.L. (2001). The cytoplasmic and transmembrane domains of the p75 and Trk A
receptors regulate high affinity binding to nerve growth factor.
Journal of Biological
Chemistry, 276,
32687-32695.
Evans, R.M., Hui, S., Perkins, A., Lahiri D.K., Poirier, J., and Farlow, M.R. (2004).
Cholesterol and ApoE genotype interact to influence Alzheimer disease progression.
Neurology, 62,
1869-1871.
Fagot-Campagna, A. (2000). Emergence of type 2 diabetes mellitus in children:
epidemiological evidence.
Journal of Pediatric Endocrinology and Metabolism, 13,
1395-1402.
Ferrer, I., and Gullotta, F. (1990). Down's syndrome and Alzheimer's disease: dendritic spine
counts in the hippocampus.
Acta Neuropathologica (Berlin), 79,
680-685.
Fifkova, E. (1985) A possible mechanism of morphometric changes in dendritic spines
induced by stimulation.
Cellular and Molecular Neurobiology, 5,
47-63.
Fillit, H., Ding, W.H., Buee, L., Kalman, J., Altstiel, L., Lawlor, B., and Wolf-Klein, G.
(1991). Elevated circulating tumor necrosis factor levels in Alzheimer's disease.
Neuroscience Letters, 129,
318-320.
Fiske, B.K., and Brunjes, P.C. (2000). Microglial activation in the developing rat olfactory
bulb.
Neuroscience, 96,
807-815.
Flood, D.G., Buell, S.J., Defiore, C.H., Horwitz, G.J., and Coleman, P.D. (1985). Age-related
dendritic growth in dentate gyrus of human brain is followed by regression in the 'oldest
old'.
Brain Research, 345,
366-368.
Flood, D., and Coleman, P.D. (1990). Hippocampal plasticity in normal aging and decreased
plasticity in Alzheimer's disease.
Progress in Brain Research, 83,
435-443.
